CoChat

Haematological malignancies: at the forefront of immunotherapeutic innovation

Open access

The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.

Abstract

The recent successes of cancer immunotherapies have stimulated interest in the potential widespread application of these approaches; haematological malignancies have provided both initial proofs of concept and an informative testing ground for various immune-based therapeutics. The immune-cell origin of many of the blood malignancies provides a unique opportunity both to understand the mechanisms of cancer immune responsiveness and immune evasion, and to exploit these mechanisms for therapeutic purposes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrc3907

Cites

216 of 216 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Items 201–216 of 216

Cited by

See all 86

Metadata

Authors
Bachireddy, P., Burkhardt, U. E., Rajasagi, M., & Wu, C. J.
Affiliations
  • Broad Institute (US)
  • Dana-Farber Cancer Institute (US)
Corresponding author
Wu, Catherine J.
Venue
Nature Reviews Cancer
Published
2015-03-19
Volume
15
Issue
4
Pages
201-215
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W2083691419
Cited by
85
References
215
Citations by year
2026: 7 · 2025: 7 · 2024: 9 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 8 · 2019: 7 · 2018: 4 · 2017: 11 · 2016: 11 · 2015: 7
FWCI
1.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL103532)
  • National Human Genome Research Institute (U54HG003067)
  • National Cancer Institute (P01CA206978, R01CA155010, T32CA009172, P30CA006516)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
hematologic malignancies, cancer immunotherapy, immune evasion, cancer immune response, immune checkpoint inhibitors, adoptive immunotherapy
MeSH terms
Animals, Humans, Immunotherapy, Hematologic Neoplasms, Cancer Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.